MARKET

GILD

GILD

Gilead Sciences Inc
NASDAQ
129.58
-2.48
-1.88%
After Hours: 130.87 +1.29 +1.00% 19:57 05/15 EDT
OPEN
132.27
PREV CLOSE
132.06
HIGH
132.81
LOW
129.10
VOLUME
6.64M
TURNOVER
--
52 WEEK HIGH
156.40
52 WEEK LOW
93.69
MARKET CAP
160.88B
P/E (TTM)
17.63
1D
5D
1M
3M
1Y
5Y
1D
A Look At Gilead Sciences (GILD) Valuation After The Recent Share Price Pullback
Simply Wall St · 18h ago
FDA leadership fallout continues as acting CDER Director Hoeg expected to depart
Seeking Alpha · 1d ago
MUBADALA INVESTMENT CO PJSC - CHANGE IN HOLDINGS ARE AS OF MARCH 31, 2026, AND COMPARED WITH THE PREVIOUS QUARTER ENDED AS OF DEC 31, 2025
Reuters · 1d ago
Reported Earlier, Gilead Sciences Prices $3B Senior Unsecured Notes In Four Tranches: $500M At 4.250% Due 2028, $1B At 4.400% Due 2029, $1B At 4.600% Due 2031 And $500M At 4.900% Due 2034
Benzinga · 1d ago
Gilead Sciences prices $3B multi-tranche senior notes offering
Seeking Alpha · 1d ago
GILEAD PRICES $3 BILLION OF SENIOR UNSECURED NOTES
Reuters · 2d ago
GILEAD: FILES FOR FOUR PART SENIOR NOTES OFFERING OF UP TO $3 BLN - SEC FILING
Reuters · 2d ago
Biopharmas look to China, elsewhere for partnerships, R&D
Seeking Alpha · 2d ago
More
About GILD
Gilead Sciences, Inc. is a biopharmaceutical company. It is engaged in advancing medicines to prevent and treat life-threatening diseases, including HIV, viral hepatitis, COVID-19, cancer, and inflammation. It is focused on discovering, developing, and delivering medicines to address unmet medical needs in virology, oncology, and other therapeutic areas. Its portfolio of marketed products includes AmBisome, Atripla, Biktarvy, Cayston, Complera, Descovy, Descovy for PrEP, Emtriva, Epclusa, Eviplera, Genvoya, Harvoni, Hepcludex, Hepsera, Jyseleca, Letairis, Livdelzi/Lyvdelzi, Odefsey, Sovaldi, Stribild, Sunlenca, Tecartus, Trodelvy, Truvada for PrEP, and others. It also sells and distributes authorized generic versions of Epclusa and Harvoni in the United States through its subsidiary, Asegua Therapeutics LLC. It has control on anitocabtagene autoleucel (anito cel), an investigational BCMA-directed CAR T cell therapy for multiple myeloma. It operates in over 35 countries worldwide.

Webull offers Gilead Sciences, Inc stock information, including NASDAQ: GILD real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, GILD stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading GILD stock methods without spending real money on the virtual paper trading platform.